Suchergebnisse

Have you assessed how the international operations of Equifax (EFX) performed in the quarter ended March 2026? For this credit reporting company, possessing an expansive global footprint, parsing

Orion S.A. OEC is currently trading at a discount to its industry. The market is assigning Orion some recovery value, while still demanding a discount for a near-term earnings reset. That frames the

Orion S.A. OEC is heading into a tougher earnings bridge in 2026, with management guiding to a lower profit run-rate as pricing resets and demand stay uneven. The setup puts more weight on

The artificial intelligence (AI) space remains rock solid, supported by an extremely bullish demand scenario. As a result, AI trade regained momentum after facing a short-term hurdle. Four major

As defense technologies advance, investors are increasingly focusing on companies that contribute to the development of unmanned systems, sensing capabilities and imaging solutions. Two prominent

The first-quarter 2026 earnings season has started with strong momentum. So far, major banks and financial institutions have reported their quarterly numbers. As of April 24, 138 companies from the

Defense and security autonomy is moving from development to deployment, and that shift is setting up a multi-year tailwind. Ondas Inc. ONDS pivoted into that deployment cycle during 2025 as its

General Mills, Inc. GIS is leaning on a strategic pivot toward heightened innovation and brand investment to revitalize its top-line performance. As part of its "Remarkable Experience Framework,"

Ondas Inc. ONDS has delivered an eye-catching run, with shares up 1304.6% over the past year and 8.1% year to date as of April 24, 2026.

That kind of move can change the entry-timing math. The stock

TTM Technologies TTMI is gaining momentum as demand from artificial intelligence (AI) and defense markets accelerates. These structural tailwinds are increasing system complexity and extending

Even though Intel INTC was once the world’s largest semiconductor company, the chip giant is on the cusp of an improbable turnaround.

Notably, Wall Street’s tone has flipped from “Intel is dying”

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

ImmunityBio IBRX is moving from a U.S.-led launch to a broader international rollout. Authorizations now span the United States, the United Kingdom, the European Union, Saudi Arabia, and Macau

Investors might want to bet on Docebo Inc. (DCBO), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum

Investors might want to bet on Cass Information Systems (CASS), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price

The first-quarter 2026 reporting cycle for the Medical sector is about to accelerate, as most companies are scheduled to release results over the next two weeks. The earnings season for the drug and

Shares of Organon OGN jumped 16% in pre-market trading after the company and India’s Sun Pharmaceutical Industries Limited jointly announced a definitive agreement. Per the agreement, Sun Pharma